JAN 10, 2018 1:28 PM PST

New Treatment on the Horizon for Marburg Virus

WRITTEN BY: Kara Marker

For the first time, scientists have been able to gather evidence for a new antibody-based drug to treat people infected with the Marburg virus, a microorganism experts say has virtually the same “pandemic potential” as Ebola.

An antibody called MR191 can neutralize the deadly Marburg virus. Credit: Ollmann Saphire Lab

From the Scripps Research Institute, scientists are studying the structure of the Marburg virus to learn more about how to neutralize it. The virus was named for its discovery in 1967 in Marburg, Germany. Its reservoir host is the African fruit bat, Rousettus aegyptiacus, and an infection with the Marburg virus usually results in fever, chills, headache, and muscle pain.

There are no treatment options aside from going to the hospital, where medical professionals can provide fluids and electrolytes, maintenance of oxygen status and blood pressure, and treatment for complicating infections. For a person infected with the Marburg virus, the fatality rate falls between 23 and 90 percent.

The new research coming from the Scripps Research Institute is based on past findings where scientists worked with an antibody called MR191, which has been shown to neutralize the Marburg virus. In the new study, scientists discover and demonstrate how.

They started by designing a map of the virus’s structure to find out how MR191 targets the Marburg virus. They did so via a high-resolution imaging technique called x-ray crystallography. Apparently, MR191 neutralizes the Marburg virus by binding a certain spot on the surface of the virus, preventing it from using that spot to bind human cells and spreading infections.

"With this new structure, we can start to see how this treatment works," explained first author Liam King. "We have also learned new things about the virus itself that could lead to new treatments and vaccines."

The study also resulted in King and others identifying a few ways the Marburg virus is different from Ebola, meaning the new drug won’t be a one-size fits all solution. It also explains why the search for an effective Ebola virus has been fraught with obstacles.

Going forward, the study researchers plan on figuring out how mutations in the Marburg virus could potentially thwart the neutralizing effects of the MR191 antibody to be used in future drug development. Second-line treatments - backups - will always be needed. Meanwhile, researchers will go ahead with preparing clinical trials for the experimental antibody-based drug approach.

The present study was published in the journal Cell Host & Microbe.

Sources: Centers for Disease Control and Prevention, Scripps Research Institute

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 12, 2021
Drug Discovery & Development
Preventing future pandemics - Scientists developing broadly protective vaccines against coronaviruses
OCT 12, 2021
Preventing future pandemics - Scientists developing broadly protective vaccines against coronaviruses
Researchers at Japan’s Osaka University recently developed and tested a novel vaccine that may protect a ...
NOV 16, 2021
Immunology
How a BBQ Lighter Inspired a New Vaccine Technology
NOV 16, 2021
How a BBQ Lighter Inspired a New Vaccine Technology
It’s the size of a pen, weighs as much as two AA batteries, and works without a power source. A new microneedle de ...
DEC 16, 2021
Health & Medicine
Could Stem Cells Cure Type 1 Diabetes?
DEC 16, 2021
Could Stem Cells Cure Type 1 Diabetes?
For people living with chronic diseases like Type 1 diabetes, the word "cure" sounds too good to be true. In f ...
DEC 23, 2021
Immunology
Double Whammy Cytokine Hit Stops Transplant Side Effects
DEC 23, 2021
Double Whammy Cytokine Hit Stops Transplant Side Effects
  Patients who receive bone marrow or stem cell transplants are offered the gift of a new lease of life. However, s ...
JAN 13, 2022
Immunology
Convalescent Plasma Therapy 'Keeps up' With COVID Variants
JAN 13, 2022
Convalescent Plasma Therapy 'Keeps up' With COVID Variants
A recent study has demonstrated that COVID-19 convalescent plasma treatment (or blood from individuals who have recovere ...
JAN 10, 2022
Microbiology
A Specific Microbe is Associated with Worsening Lupus
JAN 10, 2022
A Specific Microbe is Associated with Worsening Lupus
We are closely connected to the microbes in our gastrointestinal tract. They have a significant influence on various asp ...
Loading Comments...